1975 Nobel Prize in Physiology or Medicine — Baltimore, Dulbecco, and Temin: Reverse Transcriptase Reverses the Direction of Genetic Information Flow

What You Will Learn in This Article

Understand how the central dogma of molecular biology, "DNA → RNA → Protein," a principle defining the direction of information flow, can be reversed — the story of three scientists who discovered reverse transcriptase, an enzyme that allows information to flow from RNA back to DNA. Learn about Rous's 1911 discovery of how oncogenic viruses insert themselves into cellular genes and the precise mechanism. Finally, explore how this discovery forms the theoretical foundation for today’s HIV diagnostics, PCR, mRNA vaccines, and gene therapy.

A Story Different from Conventional Wisdom — Is Information Flow Unidirectional?

The central dogma of molecular biology, proposed by Crick in 1958, states that DNA → RNA → Protein — genetic information flows in this direction. DNA is transcribed into RNA, and RNA is translated into protein. The flow of information between these three levels is always unidirectional.

Why was this principle considered natural? DNA serves as the information storage, RNA as a working copy, and protein as the functional output. It seemed natural for information to flow from storage to execution, and for the execution output to revert back to storage. It’s like trying to reconstruct source code from an executable file.

Let's set out the background of this discovery. The view that viruses could cause tumors began to be suspected only after Rous (Peyton Rous, 1966 Nobel laureate) reported in 1909 that a virus-like agent could induce tumors in chicken muscle. However, until the electron microscope arrived, the very existence of viruses could not be firmly established, and the hypothesis that viruses cause tumors sat in limbo for decades, untested by rigorous experimentation.

In 1966, Rous received belated recognition 55 years later (see previous article), confirming the existence of oncogenic viruses. However, the mechanism of how viruses induce cancer in cells remained a mystery.

The three awardees solved this mystery by demonstrating that retroviruses, which use RNA as their genetic material, infect cells and convert their RNA back into DNA, inserting it into the cell's genome. This reverse conversion is catalyzed by reverse transcriptase.

In the language of computer science, this discovery represents the confirmation of the existence of a "reverse compiler." Previously, it was thought that compilers only translated from source code to executable files. Now, it has been confirmed that a tool exists in nature that can convert an executable file back into source code.

The Zeitgeist — The End of an Era of the Cold War

1975 was the year when one era of the Cold War clearly came to an end.

In world history, April 30 marked the fall of Saigon — the iconic image of U.S. Marines evacuating from the roof of the Saigon embassy by helicopter. This signified the end of the 20-year Vietnam War and the first clear military defeat for the United States. On April 4, Bill Gates and Paul Allen founded Microsoft in Albuquerque, marking the beginning of the personal computer era. In November, the death of Spanish dictator Francisco Franco marked the beginning of Spain's democratization. The UN designated this year as the International Year of the Woman. In June, Indira Gandhi, Prime Minister of India, declared a state of emergency.

In Korean history, it was a time when the Yushin system’s control was strengthened, along with the first anniversary of the August 15 assassination attempt. In April, eight individuals involved in the Inhyukdang incident were sentenced to death and executed the following day (a representative case of judicial murder).

In this year of upheaval, the Nobel Committee recognized the discovery of reverse transcriptase. In the year when the major political currents reversed, the concept of biological information flow was also overturned.

The Three Laureates — A Meeting During High School Summer Vacation

David Baltimore (1938–) is an American virologist. He obtained his Ph.D. from Rockefeller University (1964), became a professor at the Massachusetts Institute of Technology (MIT) (1972–1997), and served as president of the California Institute of Technology (Caltech) (1998–). At the age of 27, he was already a renowned prodigy, and at 37, he received the Nobel Prize — a very young laureate.

Howard M. Temin (1934–1994) was an American virologist. He received his Ph.D. from the California Institute of Technology (Caltech) (1959) and was a professor at the University of Wisconsin (1960–1994).

The connection between the two is unusual. The relationship between Temin and Baltimore reaches back to high school. Temin regularly attended the summer biology program for high school students run by the renowned Jackson Biology Research Institute from 1949 onward, and the wide range of biological experiential learning he encountered there decisively shaped the decision of both men to pursue careers in biology.

The story of two young men who met at a high school summer program and became Nobel laureates 40 years later — a prime example of the power of early science experiences.

Renato Dulbecco (1914–) was an Italian-born American virologist. He received his medical degree from the University of Turin (1936) and served as a senior researcher at the Salk Institute for Biological Studies (1977–1992), and later as a professor emeritus. As we saw in the previous article (1969), Delbrück was the one who steered Dulbecco toward tumor virus research — this is an extension of the phage-group lineage in the flesh.

His decisive contribution can be summarized this way. Dulbecco worked out the mechanism by which viruses cause tumors, and that achievement went on to trigger a wave of research on various cancer-causing viruses and their specific genes — producing a decisive advance in the understanding of the mechanism of carcinogenesis. According to the principle he uncovered, most transformed host cells become cancerous under the influence of the oncogenes of the virus. A gene that induces cancer is termed an oncogene, and Dulbecco’s research made a molecular-genetic approach to the mechanism of cancer possible. In the current that followed, dozens of oncogenes were discovered in viruses.

In other words, Dulbecco elucidated the mechanism by which viruses induce cancer in cells, while Baltimore and Temin discovered the physical key (reverse transcriptase) to that mechanism.

The Decisive Discovery — Reverse Transcriptase

Baltimore and Temin independently discovered reverse transcriptase in 1970. This was the moment when they demonstrated that information could physically flow from RNA to DNA.

Retroviruses — which carry RNA as their genetic material and pass through a DNA-synthesis step to replicate — became a target of intense biological interest in the wake of this discovery. The reason is clear — the human T-cell leukemia virus (HTLV), which causes leukemia, and the human immunodeficiency virus (HIV), which causes AIDS, are both retroviruses.

The infection cycle of retroviruses is as follows:

• RNA virus enters the cell — injecting its RNA into the cell.
• Reverse transcriptase is activated — the reverse transcriptase contained within the virus uses its RNA as a template to synthesize complementary DNA. RNA → DNA. The reverse of the central dogma.
• DNA insertion — the synthesized DNA is inserted into the cell's chromosomal DNA. It now becomes part of the cell's genetic information.
• Viral gene expression — the inserted viral DNA is expressed like a normal gene in the cell. The cell uses its own ribosomes and resources to produce viral proteins.
• Virus assembly and release — new viral particles are assembled and released from the cell.

The key feature of this cycle is that the viral gene is permanently inserted into the cell's genome. The inserted viral DNA is transmitted to daughter cells when the cell divides. This integration is the reason why HIV infection is so difficult to cure today — it is practically impossible to remove only the viral DNA from the cell without killing the cell.

The Legacy That Continues Today

The industrial ripple effect of reverse transcriptase extends surprisingly far.

After Temin and Baltimore's discovery, scientists could now use reverse transcriptase to synthesize cDNA from mRNA, and when this was combined with the polymerase chain reaction (PCR), the ability to amplify specific genes became a reality — a pairing that opened up the practical feasibility of gene cloning. Beyond that, reverse transcriptase is now an indispensable tool in AIDS diagnostics, and it has become a crucial enzyme in the production of drugs such as insulin and TPA, the latter of which dissolves blood clots and prevents heart attacks.

Reverse transcriptase is also decisive in gene therapy. Complementary cDNA can be made from the mRNA of a healthy individual, joined to a delivery vector, and assembled into a recombinant DNA construct — which then makes it possible to efficiently introduce a normal gene into a patient's cells. In this context, reverse transcriptase is used broadly across today's genetic engineering and has become one of the foundational tools of biotechnology as a whole.

This flow leads to what we see today:

• HIV diagnostics: PCR-based diagnostics, which detect HIV by converting its RNA into DNA, are now standard. Viral load quantification.
• HIV treatment (HAART): Drugs that inhibit reverse transcriptase (e.g., AZT, lamivudine) are the cornerstone of HIV treatment. HIV is now a manageable chronic disease.
• mRNA vaccines (COVID): Artificial mRNA is used to induce cells to produce antigen proteins. The cDNA synthesis step, which utilizes reverse transcriptase, is used in the mRNA vaccine development pipeline.
• Gene therapy vectors: Lentiviral (HIV-derived) vectors are used to stably insert therapeutic genes into patient cells. Used in CAR-T cell therapy.
• PCR diagnostics (more accurately, RT-PCR): The standard for COVID diagnostics. Viral RNA is converted to cDNA and then amplified by PCR. This technology is essential for pandemic response.
• Recombinant insulin, TPA, etc.: As noted above, many recombinant protein drugs are produced using reverse transcriptase.
• Oncogene research: Starting with Dulbecco's discovery, numerous oncogenes have been identified, leading to the development of targeted therapies.

Why It Matters

What Baltimore, Dulbecco, and Temin left behind is the empirical evidence that "the principles of information flow in nature are more flexible than we thought."

While the central dogma was considered to be a unidirectional flow, nature had already created a reverse tool. Why did this discovery have such a significant impact? Because it teaches a cautious skepticism towards the absoluteness of principles. Any "obvious" principle may have exceptions in the real world.

And the surprising implication that when a principle is reversed, it becomes a tool. The exception in nature (reverse transcriptase of retroviruses) has transformed into a key tool in molecular biology. Many of today’s genetic engineering, vaccines, gene therapy, and precision diagnostics depend on this enzyme. A case where the violation of a principle becomes the discovery of a tool.

The story of two young men who met at a high school summer program and became Nobel laureates 40 years later — a prime example of how impactful early science experiences can be. It remains a representative case for justifying science programs for young people in various countries today.

1975 Baltimore, Dulbecco, and Temin Summary: Baltimore and Temin independently discovered reverse transcriptase in 1970, which synthesizes DNA from RNA. This demonstrated that the direction of information flow can be reversed in nature. Dulbecco elucidated the mechanism by which viruses insert themselves into the cell's genome, causing cancer. This forms the theoretical basis for today's HIV diagnostics, treatment, PCR, mRNA vaccines, and gene therapy.

← Previous: 1974 — Claude, de Duve, and Palade → Next: 1976 — Blumberg and Gajdusek